Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.
Rodent studies and clinical trials increasingly demonstrate the soothing effects of green light, and now, researchers are revealing the underlying neural mechanisms.
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.